Search research articles
Contact Us
Filters
Showing results (51-60 of 292) with videos related to
Page
of 30
Sort By:
Drug Design, Development and Therapy
|
December 13, 2024
Safety, Tolerability and Pharmacokinetics of Intravenous Sodium Taurodeoxycholate, HY209, a GPCR19 Agonist Inhibiting Inflammasomal Activation
Woo Kyung Chung, Inseung Jeon, In-Jin Jang, et al.
Clinical and Translational Science
|
December 4, 2021
Endogenous metabolic markers for predicting the activity of dihydropyrimidine dehydrogenase
Jihyun Kang, Andrew HyoungJin Kim, Inseung Jeon, et al.
Clinical Drug Investigation
|
October 26, 2013
Pharmacokinetics, safety and tolerability of DA-6034, an anti-inflammatory agent, after single and multiple oral administrations in healthy volunteers
Jieon Lee, Kwang-Hee Shin, Jung-Ryul Kim, et al.
Clinical Pharmacology in Drug Development
|
March 1, 2021
Pharmacokinetic Interaction Among Ezetimibe, Rosuvastatin, and Telmisartan
Ki Young Huh, Sang Won Lee, Si Beum Lee, et al.
Drug Design, Development and Therapy
|
April 26, 2016
Pharmacokinetics of the evogliptin/metformin extended-release (5/1,000 mg) fixed-dose combination formulation compared to the corresponding loose combination, and food effect in healthy subjects
Su-Jin Rhee, SeungHwan Lee, Seo Hyun Yoon, et al.
Clinical and Translational Science
|
December 14, 2022
Pharmacokinetics, safety and tolerability of valbenazine in Korean CYP2D6 normal and intermediate metabolizers
Woo Kyung Chung, Inyoung Hwang, Byungwook Kim, et al.
British Journal of Clinical Pharmacology
|
April 8, 2022
Dose-dependent glucosuria of DWP16001, a novel selective sodium-glucose cotransporter-2 inhibitor, in healthy subjects
Jun Gi Hwang, SeungHwan Lee, Wan Huh, et al.
British Journal of Clinical Pharmacology
|
October 14, 2025
Pharmacokinetics, pharmacodynamics and safety of vutiglabridin after multiple oral administrations in healthy female and obese subjects
Sooyoun Lee, Hyun Chul Kim, Young Ran Yoon, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
October 3, 2003
Sensitive liquid chromatography assay with ultraviolet detection for a new phosphodiesterase V inhibitor, DA-8159, in human plasma and urine
Joo Youn Cho, Hyeong Seok Lim, Kyung Sang Yu, et al.
Clinical Therapeutics
|
November 18, 2011
Comparative pharmacokinetics and tolerability of branded etanercept (25 mg) and its biosimilar (25 mg): a randomized, open-label, single-dose, two-sequence, crossover study in healthy Korean male volunteers
Namyi Gu, Sojeong Yi, Tae-Eun Kim, et al.
Page
of 30
Search research articles
Search
Showing results (51-60 of 292) with videos related to
Sort By:
Page
of 30
Drug Design, Development and Therapy
|
December 13, 2024
Safety, Tolerability and Pharmacokinetics of Intravenous Sodium Taurodeoxycholate, HY209, a GPCR19 Agonist Inhibiting Inflammasomal Activation
Woo Kyung Chung, Inseung Jeon, In-Jin Jang, et al.
Clinical and Translational Science
|
December 4, 2021
Endogenous metabolic markers for predicting the activity of dihydropyrimidine dehydrogenase
Jihyun Kang, Andrew HyoungJin Kim, Inseung Jeon, et al.
Clinical Drug Investigation
|
October 26, 2013
Pharmacokinetics, safety and tolerability of DA-6034, an anti-inflammatory agent, after single and multiple oral administrations in healthy volunteers
Jieon Lee, Kwang-Hee Shin, Jung-Ryul Kim, et al.
Clinical Pharmacology in Drug Development
|
March 1, 2021
Pharmacokinetic Interaction Among Ezetimibe, Rosuvastatin, and Telmisartan
Ki Young Huh, Sang Won Lee, Si Beum Lee, et al.
Drug Design, Development and Therapy
|
April 26, 2016
Pharmacokinetics of the evogliptin/metformin extended-release (5/1,000 mg) fixed-dose combination formulation compared to the corresponding loose combination, and food effect in healthy subjects
Su-Jin Rhee, SeungHwan Lee, Seo Hyun Yoon, et al.
Clinical and Translational Science
|
December 14, 2022
Pharmacokinetics, safety and tolerability of valbenazine in Korean CYP2D6 normal and intermediate metabolizers
Woo Kyung Chung, Inyoung Hwang, Byungwook Kim, et al.
British Journal of Clinical Pharmacology
|
April 8, 2022
Dose-dependent glucosuria of DWP16001, a novel selective sodium-glucose cotransporter-2 inhibitor, in healthy subjects
Jun Gi Hwang, SeungHwan Lee, Wan Huh, et al.
British Journal of Clinical Pharmacology
|
October 14, 2025
Pharmacokinetics, pharmacodynamics and safety of vutiglabridin after multiple oral administrations in healthy female and obese subjects
Sooyoun Lee, Hyun Chul Kim, Young Ran Yoon, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
October 3, 2003
Sensitive liquid chromatography assay with ultraviolet detection for a new phosphodiesterase V inhibitor, DA-8159, in human plasma and urine
Joo Youn Cho, Hyeong Seok Lim, Kyung Sang Yu, et al.
Clinical Therapeutics
|
November 18, 2011
Comparative pharmacokinetics and tolerability of branded etanercept (25 mg) and its biosimilar (25 mg): a randomized, open-label, single-dose, two-sequence, crossover study in healthy Korean male volunteers
Namyi Gu, Sojeong Yi, Tae-Eun Kim, et al.
Page
of 30